Medifast (MED) Tops Q4 EPS by 9c, Revenues Beat; Offers EPS/Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Medifast, Inc. Announces Fourth Quarter and Full Year 2018 Financial Results
February 26, 2019 4:16 PM ESTBALTIMORE, Feb. 26, 2019 /PRNewswire/ --Â Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven, healthy living products and programs, today reported financial results for the fourth quarter and full year ended December 31, 2018.
Fourth Quarter 2018 Highlights:
Revenue of $145.8 million, an increase of 87.0% year-over-year Active earning Coaches of 24,100, an increase of 60.7% year-over-year Net income of $15.7 million, an increase of 114.2%... More


